BLAKE BECHTLE: Open Payments
NPI 1386356657 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 51 payments from 10 companies in 2025. Trend: 2023 $104 · 2024 $466 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $242 |
| Lilly USA, LLC | 3 | $53 |
| Medtronic, Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Exeltis, USA Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| PFIZER INC. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: VRAYLAR, QULIPTA, UBRELVY, INCEPTIV, MOUNJARO, LEQVIO, SLYND, FREESTYLE LIBRE 3.
Industry payments across ID — which companies pay providers there.
